InsidersTradesSigma
Follow the SB성보 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, SB성보 has published 47 public disclosures. Market capitalisation: €5.3bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: 윤정선. All data is accessible without an account.
Analysts rate SB성보 Buy (bullish), based on 8 analysts. Average price target: €42.88.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 47 declarations
SB성보是一家在XKRX市场上市的医疗保健和制药领域的公司。